Apyx Medical (APYX) Income towards Parent Company (2011 - 2026)

Apyx Medical (APYX) has 15 years of Income towards Parent Company data on file, last reported at -$2.1 million in Q1 2026.

• Quarterly Income towards Parent Company rose 48.63% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.1 million (up 45.91% YoY) and the FY2025 annual result came in at -$14.1 million, up 45.21% from the prior year.
• Income towards Parent Company advanced to -$2.1 million in Q1 2026, from -$4.3 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of -$1.0 million in Q2 2023 to a low of -$9.6 million in Q4 2023.
• A 5-year average of -$5.0 million and a median of -$4.7 million in 2024 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2023 — Income towards Parent Company jumped 81.3% — and 2024, when it sank 546.32%.
• Tracing APYX's Income towards Parent Company over 5 years: stood at -$6.1 million in 2022, then sank by 58.68% to -$9.6 million in 2023, then advanced by 28.5% to -$6.9 million in 2024, then jumped by 38.09% to -$4.3 million in 2025, then soared by 49.69% to -$2.1 million in 2026.
• The last three Income towards Parent Company figures came in at -$2.1 million (Q1 2026), -$4.3 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.